About this episode

David Armstrong investigates the shocking price increase of a cancer drug and its implications for the healthcare system.

Reporter David Armstrong was diagnosed with cancer and soon learned that one of his drugs would cost almost $1,000 per pill. He set out to discover why, and uncovered financial records and legal filings that shocked him. The drugmaker’s strategy to raise the price over and over again helps explain why our healthcare system is the most expensive in the world. Read the original reporting: https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma Support our journalism by donating at propublica.org/donate .

People in this episode

Guest: David Armstrong

Topics covered

• healthcare costs
• pharmaceutical pricing
• cancer treatment
• drug industry
• financial records
• legal filings

Keywords

• cancer
• drug pricing
• healthcare
• Revlimid
• Celgene
• financial records
• legal filings
• pharmaceuticals

Mentioned in this episode

Organizations: ProPublica, Celgene, FDA

Products: Revlimid

More episodes of Paper Trail

• The Predatory Industry Behind MLB’s Dominican Superstar Pipeline · September 10, 2026 · 44 min
• How the Planet-Altering Disaster of “Forever Chemicals” Was Kept Secret · September 3, 2026 · 44 min
• The True Story of Why Immigration Agents Raided a Chicago Apartment Building · August 20, 2026 · 42 min
• How “Forgive and Forget” Buried a Church’s Dark Secret · August 6, 2026 · 46 min
• What Happened When Trump Officials Destroyed USAID (From Reveal) · July 23, 2026 · 34 min
• How Microsoft’s “Little Workaround” Created a Major Pentagon Threat · July 9, 2026 · 34 min

Explore listener stats, chart rankings, contacts and more on the Paper Trail podcast page.